Internal Medicine, Cardiovascular Disease · Rochester, MN
NPI
1336580935
Since 2013
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
200 1st St SW
Rochester, MN, 55905
Phone (507) 284-2511
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
365 services
Medicare patients, 2024
175
Average age 68
Drug cost, 2024
$709K
1,762 prescriptions
Company payments, 2025
$927
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew N Rosenbaum was code 99233 (hospital e&m - subsequent), 123 times for 33 patients. In total Andrew N Rosenbaum billed 365 services in 21 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 123 | 33 | $88.61 | $11K |
| 99215 Office E&M - Established | Office | 95 | 84 | $140.16 | $13K |
| 99205 Office E&M - New | Office | 30 | 30 | $178.60 | $5,358 |
| 99214 Office E&M - Established | Office | 25 | 25 | $96.49 | $2,412 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 23 | 21 | $13.31 | $306 |
By year: 2022 $44K for 487 services; 2023 $40K for 387 services; 2024 $36K for 365 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew N Rosenbaum prescribed most often to Medicare patients was Metoprolol Succinate, with 142 prescriptions and refills. In total Andrew N Rosenbaum wrote 1,762 Medicare prescriptions that cost $709K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 142 | 336 | 46 | $2,265 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 133 | 277 | 37 | $928 |
| Entresto Sacubitril/Valsartan | 122 | 237 | 33 | $141K |
| Rosuvastatin Calcium Generic | 99 | 262 | 39 | $1,083 |
| Jardiance Empagliflozin | 95 | 238 | 38 | $138K |
| Spironolactone Generic | 88 | 214 | 28 | $790 |
| Farxiga Dapagliflozin Propanediol | 71 | 137 | 16 | $74K |
| Losartan Potassium Generic | 66 | 166 | 18 | $1,074 |
| Furosemide Generic | 56 | 132 | 22 | $420 |
| Mycophenolate Mofetil Generic | 55 | 125 | 17 | $4,574 |
| Prednisone Generic | 54 | 99 | 17 | $474 |
| Eliquis Apixaban | 54 | 118 | 15 | $65K |
| Torsemide Generic | 52 | 131 | 22 | $2,074 |
| Carvedilol Generic | 52 | 134 | 15 | $689 |
| Bisoprolol Fumarate Generic | 45 | 125 | 16 | $1,263 |
Brand drugs: 405 claims; generic drugs: 1,357 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew N Rosenbaum $927 ($927 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbott Laboratories with $749.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.